Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,802 | 15,354 | 16,756 | 2,920 | 5,943 |
| Other current assets | 114 | 134 | 169 | 125 | 269 |
| TOTAL | $38,916 | $15,488 | $16,925 | $3,045 | $6,212 |
| Non-Current Assets | |||||
| PPE Net | 28 | 36 | 29 | 23 | 66 |
| Other Non-Current Assets | 630 | 608 | 130 | 144 | 224 |
| TOTAL | $658 | $644 | $159 | $167 | $290 |
| Total Assets | $39,574 | $16,132 | $17,084 | $3,212 | $6,502 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 364 | 795 | 597 | 65 | 260 |
| Accrued Expenses | 1,140 | 593 | 905 | 224 | 461 |
| TOTAL | $1,504 | $1,388 | $1,502 | $305 | $754 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 16 | 33 |
| TOTAL | $N/A | $3 | $1 | $N/A | $16 |
| Total Liabilities | $1,504 | $1,391 | $1,503 | $305 | $770 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42 | 14 | 14 | 2 | 1 |
| Common Shares | 9 | 3 | 16 | 3 | 2 |
| Retained earnings | -96,067 | -84,622 | -74,933 | -67,994 | -63,674 |
| TOTAL | $38,070 | $14,741 | $15,581 | $2,907 | $5,732 |
| Total Liabilities And Equity | $39,574 | $16,132 | $17,084 | $3,212 | $6,502 |